News
CNTX
1.575
+15.81%
0.215
BUZZ-U.S. STOCKS ON THE MOVE-Howmet Aerospace, Peloton, Freshworks
U.S. Stock index futures advanced on Thursday. Dow e-minis were up 0.51% in early trading. Federal Reserve left interest rates unchanged and allayed fears of potential rate hikes. Top three NYSE percentage gainers: Carvana, Howmet Aerospace, Peloton, Freshworks.
Reuters · 2h ago
Context Therapeutics Inc: Current report
Press release · 3h ago
BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Rush Street, MGM Resorts
U.S. Stock index futures advanced on Thursday. Dow e-minis were up 0.41% at 38,226.5. Federal Reserve left interest rates unchanged and allayed fears of potential rate hikes. Top three NYSE percentage gainers premarket: Carvana, Rush Street, MGM Resorts.
Reuters · 3h ago
CONTEXT THERAPEUTICS: COMPANY EXPECTS TO ENROLL FIRST PATIENT IN MID-2024
Reuters · 3h ago
CONTEXT THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR A PHASE 1 CLINICAL TRIAL OF CTIM-76
Reuters · 3h ago
CONTEXT THERAPEUTICS - PROCEEDS, ALONG WITH EXISTING CASH AND CASH EQUIVALENTS, ARE EXPECTED TO EXTEND CASH RUNWAY INTO 2028
Reuters · 3h ago
Weekly Report: what happened at CNTX last week (0422-0426)?
Weekly Report · 3d ago
Weekly Report: what happened at CNTX last week (0415-0419)?
Weekly Report · 04/22 10:04
Weekly Report: what happened at CNTX last week (0408-0412)?
Weekly Report · 04/15 10:00
Weekly Report: what happened at CNTX last week (0401-0405)?
Weekly Report · 04/08 10:03
CONTEXT THERAPEUTICS SUBMITS IND APPLICATION TO EVALUATE CTIM-76 IN CLAUDIN 6-POSITIVE CANCERS
Reuters · 04/01 11:30
Weekly Report: what happened at CNTX last week (0325-0329)?
Weekly Report · 04/01 10:02
Weekly Report: what happened at CNTX last week (0318-0322)?
Weekly Report · 03/25 10:03
Weekly Report: what happened at CNTX last week (0311-0315)?
Weekly Report · 03/18 10:02
Weekly Report: what happened at CNTX last week (0304-0308)?
Weekly Report · 03/11 10:01
Weekly Report: what happened at CNTX last week (0226-0301)?
Weekly Report · 03/04 10:03
Weekly Report: what happened at CNTX last week (0219-0223)?
Weekly Report · 02/26 10:08
Weekly Report: what happened at CNTX last week (0212-0216)?
Weekly Report · 02/19 10:09
Weekly Report: what happened at CNTX last week (0205-0209)?
Weekly Report · 02/12 10:04
Weekly Report: what happened at CNTX last week (0129-0202)?
Weekly Report · 02/05 10:08
More
Webull provides a variety of real-time CNTX stock news. You can receive the latest news about Context Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About CNTX
Context Therapeutics Inc. is a biopharmaceutical company advancing medicines for solid tumors. The Company is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, which is in preclinical development. CLDN6 is a tight junction membrane protein target expressed in multiple solid tumors, including ovarian, endometrial, testicular, and lung, and absent from or expressed at low levels in healthy adult tissues. CTIM-76 is capable of binding to tumor cells expressing CLDN6 and stimulating intra-tumoral T cells by the CD3 arm that is designed to be activated only upon tumor engagement while silent elsewhere. CTIM-76 has the potential for a wide therapeutic window, which is the difference between the dose required for the intended therapeutic effect and the dose required to elicit an unwanted side effect.